The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Mucins in the gastrointestinal tract in health and disease
Open accessAbstract
Mucins form part of the dynamic, interactive mucosal defensive system active at the mucosal surface of the gastrointestinal tract. They are carbohydrate rich glycoproteins with unique molecular structure and chemical properties. The family of mucin (MUC) genes has 13 members that can be divided into secreted and membrane-associated forms each with characteristic protein domains and tissue specific glycosylation. Biosynthetic pathways have been described for the secreted and membrane-associated mucins and their eventual degradation and turnover. Mucins are present at all mucosal surfaces throughout the body in typical combinations and relate to the demands of organ function. Patterns of MUC gene expression with gastrointestinal site specific glycosylation are clearly important but are not yet well defined. Mucin production during fetal development shows distinct patterns that may correlate in many cases with neoplastic expression in adult life. An increasing number of protective proteins have been identified that appear in the adherent mucus layer at the mucosal surface. These proteins are co-secreted with mucins in some cases, interact with mucins at a molecular level through peptide and carbohydrate sites or benefit from the viscoelastic, aqueous environment afforded by the mucus gel to effect their defensive roles. The mechanism of many of these interaction remains to be elucidated but is clearly part of an integrated innate and adaptive mucosal defensive system relying on the mucins as an integral component to provide a mucus gel. Recent improvements in the description of MUC gene expression and mature mucin synthesis in the healthy gastrointestinal tract has formed a basis for assessment of mucosal disease at sites throughout the tract. Pathological patterns of mucin expression in disease appear to follow tissue phenotype, so that gastric and intestinal types can be defined and appear in metaplasia in e.g. esophagus and stomach. Adaptation of previous mucin based, histochemical classification of intestinal metaplasia to assess MUC gene expression has proved helpful and promises greater value if reliably combined with mucin linked glycosylation markers. Few changes in MUC gene expression or polymorphism have been detected in inflammatory bowel diseases in contrast to malignant transformation. Glycosylation changes however, are evident in both types of disease and appear to be early events in disease pathogenesis. Review of the major mucosal diseases affecting the gastrointestinal tract in childhood reveals parallel patterns to those found in adult pathology, but with some novel conditions arising through the developmental stages at lactation and weaning. The impact of bacterial colonization and nutrition at these stages of life are important in the evaluation of mucosal responses in pediatric disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wright, D. P., Rosendale, D. I., & Roberton, A. M. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09265.x · Cited by 185
MUC2 is the prominent colonic mucin expressed in ulcerative colitis.
Tytgat, K. M., Opdam, F. J., Einerhand, A. W., Büller, H. A., & Dekker, J. (1996) · Gut · doi:10.1136/gut.38.4.554 · Cited by 85
Cited by
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia
Button, B., Cai, L.-H., Ehre, C., Kesimer, M., Hill, D. B., Sheehan, J. K., Boucher, R. C., & Rubinstein, M. (2012) · Science · doi:10.1126/science.1223012 · Cited by 863
Regulation of Intestinal Barrier Function by Microbial Metabolites
Ghosh, S., Whitley, C. S., Haribabu, B., & Jala, V. R. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.02.007 · Cited by 835
Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M., & Salminen, S. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01477-07 · Cited by 706
Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin
Allen, A., & Flemström, G. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00102.2004 · Cited by 617
Liévin-Le Moal, V., & Servin, A. L. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.315-337.2006 · Cited by 568
Sulfotransferases: Structure, Mechanism, Biological Activity, Inhibition, and Synthetic Utility
Chapman, E., Best, M. D., Hanson, S. R., & Wong, C. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300631 · Cited by 543
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases
Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503
Mucins and mucin binding proteins in colorectal cancer
Byrd, J. C., & Bresalier, R. S. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025815113599 · Cited by 490
Non-starter lactic acid bacteria used to improve cheese quality and provide health benefits
Settanni, L., & Moschetti, G. (2010) · Food Microbiology · doi:10.1016/j.fm.2010.05.023 · Cited by 456
INTESTINAL CROSSTALK: A NEW PARADIGM FOR UNDERSTANDING THE GUT AS THE "MOTOR" OF CRITICAL ILLNESS
Clark, J. A., & Coopersmith, C. M. (2007) · Shock · doi:10.1097/shk.0b013e31805569df · Cited by 444
Role of the Microbiome in Energy Regulation and Metabolism
Nieuwdorp, M., Gilijamse, P. W., Pai, N., & Kaplan, L. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.008 · Cited by 421
The stomach in health and disease
Hunt, R. H., Camilleri, M., Crowe, S. E., El-Omar, E. M., Fox, J. G., Kuipers, E. J., Malfertheiner, P., McColl, K. E. L., Pritchard, D. M., Rugge, M., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307595 · Cited by 403
Loss of intestinal core 1–derived O-glycans causes spontaneous colitis in mice
Fu, J., Wei, B., Wen, T., Johansson, M. E. V., Liu, X., Bradford, E., Thomsson, K. A., McGee, S., Mansour, L., Tong, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45538 · Cited by 366
Sulfatases: Structure, Mechanism, Biological Activity, Inhibition, and Synthetic Utility
Hanson, S. R., Best, M. D., & Wong, C. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300632 · Cited by 362
Bafna, S., Kaur, S., & Batra, S. K. (2010) · Oncogene · doi:10.1038/onc.2010.87 · Cited by 360
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans
An, G., Wei, B., Xia, B., McDaniel, J. M., Ju, T., Cummings, R. D., Braun, J., & Xia, L. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061929 · Cited by 352
Andrianifahanana, M., Moniaux, N., & Batra, S. K. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.01.002 · Cited by 314
Kashyap, P. C., Marcobal, A., Ursell, L. K., Smits, S. A., Sonnenburg, E. D., Costello, E. K., Higginbottom, S. K., Domino, S. E., Holmes, S. P., Relman, D. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306070110 · Cited by 285
Mucus as a barrier to lipophilic drugs
Sigurdsson, H. H., Kirch, J., & Lehr, C.-M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.040 · Cited by 280
Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder
Newell, C., Bomhof, M. R., Reimer, R. A., Hittel, D. S., Rho, J. M., & Shearer, J. (2016) · Molecular Autism · doi:10.1186/s13229-016-0099-3 · Cited by 272
Effect of Diet on Mucin Kinetics and Composition: Nutrition and Health Implications
Montagne, L., Piel, C., & Lalles, J. P. (2004) · Nutrition Reviews · doi:10.1111/j.1753-4887.2004.tb00031.x · Cited by 259
Structure, evolution, and biology of the MUC4 mucin
Chaturvedi, P., Singh, A. P., & Batra, S. K. (2008) · The FASEB Journal · doi:10.1096/fj.07-9673rev · Cited by 252
Intestinal antimicrobial peptides during homeostasis, infection, and disease
Muniz, L. R., Knosp, C., & Yeretssian, G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00310 · Cited by 252
Metabolite profiling of fecal water extracts from human colorectal cancer
Monleón, D., Morales, J. M., Barrasa, A., López, J. A., Vázquez, C., & Celda, B. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1345 · Cited by 186
Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease
Xiao, B., & Merlin, D. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.730517 · Cited by 145
Grys, T. E., Siegel, M. B., Lathem, W. W., & Welch, R. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.3.1295-1303.2005 · Cited by 138
Glycan-dependent viral infection in infants and the role of human milk oligosaccharides
Etzold, S., & Bode, L. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.06.005 · Cited by 72
Patsos, G., Hebbe-Viton, V., Robbe-Masselot, C., Masselot, D., Martin, R. S., Greenwood, R., Paraskeva, C., Klein, A., Graessmann, M., Michalski, J. C., et al. (2009) · Glycobiology · doi:10.1093/glycob/cwn149 · Cited by 68
Characterization of the StcE Protease Activity of Escherichia coli O157:H7
Grys, T. E., Walters, L. L., & Welch, R. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.01806-05 · Cited by 51
Metadata
- Authors
- Corfield, A.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2001
- Volume
- 6
- Issue
- 1
- Pages
- d1321
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- OpenAlex
- W1598097649
- Cited by
- 344
- References
- 2
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.